Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Learn about wealth management strategies for families that can help secure your financial future and provide for your loved ones.
21,982 articlesInside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Oil rose past $100 per barrel as tensions involving Iran added a geopolitical layer to markets. Yet the S&P 500 showe...
A pullback in AbbVie has some investors asking if the stock looks like a bargain. This guide explains why that view m...
Big-cap U.S. stocks are trading at more attractive levels after a year of resilience and rising macro uncertainty. An...
Intel stock popped today as optimism about AI demand and data-center upgrades fed investor enthusiasm. This article b...
Two big reasons explain why the fear around IBM's COBOL future might be overstated. This piece breaks down why COBOL ...
A major security misconfiguration at Anthropic left internal assets, including notes on an unreleased model and CEO r...
CrowdStrike stock absolutely hammered this week, yet the dip isn’t a clear buy signal. I break down the risks, the gr...
Bernstein boosts its ServiceNow price target to $236 after the company's Analyst Day, underscoring margin upside even...
If you own rental real estate, you’ve probably wondered how to boost cash flow without waiting years for upside. A co...
Disney beats Q2 expectations, sending Wall Street into a target-upgrade cycle. JPMorgan, Barclays and Guggenheim lift...
Bitcoin slid to about $79,679 as geopolitical tensions flare, but the week remains on track for a sixth straight week...